QDENGA
INJ PSO LQF 5+5X0,5ML ISP+10J
| SÚKL code | 0271493 |
|---|---|
| Name of the product | QDENGA |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | QDENGA |
| Supplement | INJ PSO LQF 5+5X0,5ML ISP+10J |
| Strenght | |
| Pharmaceutical form | Powder and solvent for solution for injection |
| Package | 5+5X0,5ML ISP+10J |
| Route | Subcutaneous use |
| Wrap type | Vial |
| Legal status | na lékařský předpis |
| Active substance |
LIVE ATTENUATED DENGUE VIRUS SEROTYPE 1 (VIRUS DENGUAE SEROTYPUS 1 VIVUM ATTENUATUM) LIVE ATTENUATED DENGUE VIRUS SEROTYPE 2 (VIRUS DENGUAE SEROTYPUS 2 VIVUM ATTENUATUM) LIVE ATTENUATED DENGUE VIRUS SEROTYPE 3 (VIRUS DENGUAE SEROTYPUS 3 VIVUM ATTENUATUM) LIVE ATTENUATED DENGUE VIRUS SEROTYPE 4 (VIRUS DENGUAE SEROTYPUS 4 VIVUM ATTENUATUM) |
| ATC group | J07BX04 |
| ATC group name | VAKCÍNY PROTI INFEKCÍM VYVOLANÝM VIREM DENGUE |
Marketing authorisation information
| Registration Number | EU/1/22/1699/006 |
|---|---|
| Type of MA | centralised without orphans |
| MA status | R - active MA/authorised medicinal product |
| MA Holder | Takeda GmbH, Konstanz |
| MA Holder country | NĚMECKO |
cz